Additional recommendation on the use of obesity medications in diabetes patients is provided in the updated guidelines. The American Diabetes Association ® (ADA) has released its latest evidence-based ...

The American Diabetes Association’s 2026 Standards of Care reframe type 2 diabetes as a multi-system condition, integrating cardiovascular, kidney, and metabolic risk management. The guidelines ...

Late-breaking data for retatrutide, CagriSema, survodutide, and oral elecoglipron are poised to reshape near-term formulary strategy and utilization management for obesity and metabolic disease.

A new version of Medtronic’s advanced, hybrid closed-loop insulin delivery system showed it could help improve blood sugar control throughout the day in adolescents and young adults with Type 1 ...

The American Diabetes Association’s 2026 Standards of Care introduce updated protocols for inpatient diabetes management to address rising rates of severe hyperglycemic events. The guidelines ...